Uri Weinberg's most recent trade in NovoCure Ltd was a trade of 81,499 Stock Options (Right to buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 221,218 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 18.78 per share. | 03 Mar 2025 | 4,326 | 166,822 (0%) | 0% | 18.8 | 81,254 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 18.31 per share. | 03 Mar 2025 | 311 | 166,511 (0%) | 0% | 18.3 | 5,695 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 18.92 per share. | 03 Mar 2025 | 268 | 166,243 (0%) | 0% | 18.9 | 5,071 | Ordinary Shares |
| NovoCure Ltd | Weinberg Uri | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 125,078 | 125,078 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 16.30 per share. | 27 Feb 2024 | 81,799 | 171,148 (0%) | 0% | 16.3 | 1,333,324 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 30 Jun 2023 | 305 | 89,349 (0%) | 0% | 35.3 | 10,760 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 28,830 | 85,108 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 3,936 | 89,044 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 21,607 | 21,607 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 12,992 | 56,278 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 108.00 per share. | 05 Jan 2023 | 2,617 | 44,487 (0%) | 0% | 108 | 282,636 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 05 Jan 2023 | 2,379 | 47,104 (0%) | 0% | 120 | 285,480 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 1,946 | 1,946 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 05 Jan 2023 | 1,946 | 47,104 (0%) | 0% | 120 | 233,520 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.04 per share. | 05 Jan 2023 | 1,946 | 49,050 (0%) | 0% | 47.0 | 91,540 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 05 Jan 2023 | 1,201 | 43,286 (0%) | 0% | 120 | 144,120 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 59.07 per share. | 05 Jul 2022 | 281 | 49,483 (0%) | 0% | 59.1 | 16,600 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 30,422 | 30,422 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 17,371 | 49,186 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 4,961 | 4,961 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 63.83 per share. | 06 Jan 2022 | 35 | 31,815 (0%) | 0% | 63.8 | 2,234 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 137.12 per share. | 06 Jul 2021 | 113 | 31,780 (0%) | 0% | 137.1 | 15,495 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 3,846 | 3,845 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 189.65 per share. | 10 May 2021 | 3,846 | 33,471 (0%) | 0% | 189.7 | 729,394 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.56 per share. | 10 May 2021 | 3,846 | 37,317 (0%) | 0% | 47.6 | 182,916 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 189.65 per share. | 10 May 2021 | 1,804 | 31,667 (0%) | 0% | 189.7 | 342,129 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 23 Mar 2021 | 2,835 | 33,471 (0%) | 0% | 140 | 396,900 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 16,003 | 16,003 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 8,709 | 36,306 | - | 0 | Restricted Share Units | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. | 22 Feb 2021 | 6,500 | 34,097 (0%) | 0% | 7.2 | 46,475 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 6,500 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 175.50 per share. | 22 Feb 2021 | 6,500 | 27,597 (0%) | 0% | 175.5 | 1,140,750 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 8,750 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 103.35 per share. | 25 Sep 2020 | 8,750 | 27,597 (0%) | 0% | 103.4 | 904,313 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 25 Sep 2020 | 8,750 | 36,347 (0%) | 0% | 11.5 | 100,275 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. | 25 Sep 2020 | 6,500 | 34,097 (0%) | 0% | 7.2 | 46,475 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 6,500 | 6,500 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Sale of securities on an exchange or to another person at price $ 103.35 per share. | 25 Sep 2020 | 6,500 | 27,597 (0%) | 0% | 103.4 | 671,775 | Ordinary Shares |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 3,779 | 3,779 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Uri Weinberg | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 1,968 | 27,597 | - | 0 | Restricted Share Units |